(+)-schisandrin B multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC6A13 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A13 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A13 mRNA CTD PMID:36331819 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of SLC6A13 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A13 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Estradiol results in increased expression of SLC6A13 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of SLC6A13 mRNA and [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC6A13 mRNA CTD PMID:16214954 and PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A13 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A13 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC6A13 mRNA CTD PMID:18796159 and PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of SLC6A13 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of SLC6A13 mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO SLC6A13 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC6A13 mRNA CTD PMID:37199045 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 3 more ... CTD PMID:20959002 3H-1,2-dithiole-3-thione decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 1 and 2-dithiol-3-thione results in decreased expression of SLC6A13 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of SLC6A13 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of SLC6A13 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC6A13 mRNA CTD PMID:24780913 acetamide decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 acetamide results in decreased expression of SLC6A13 mRNA CTD PMID:31881176 aflatoxin B1 decreases expression ISO SLC6A13 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC6A13 mRNA CTD PMID:22100608 aflatoxin B1 increases methylation ISO SLC6A13 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC6A13 intron CTD PMID:30157460 alachlor affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 alachlor affects the expression of SLC6A13 mRNA CTD PMID:19425180 ammonium chloride affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SLC6A13 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO SLC6A13 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SLC6A13 mRNA CTD PMID:33212167 arsane affects expression ISO SLC6A13 (Homo sapiens) 6480464 Arsenic affects the expression of SLC6A13 mRNA CTD PMID:18414638 arsenic atom affects expression ISO SLC6A13 (Homo sapiens) 6480464 Arsenic affects the expression of SLC6A13 mRNA CTD PMID:18414638 benzo[a]pyrene decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Benzo(a)pyrene results in decreased expression of SLC6A13 mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO SLC6A13 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC6A13 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO SLC6A13 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of SLC6A13 5' UTR and Benzo(a)pyrene results in decreased methylation of SLC6A13 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SLC6A13 mRNA CTD PMID:19770486 more ... bisphenol A affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SLC6A13 mRNA CTD PMID:26950200 and PMID:30903817 bisphenol A increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC6A13 mRNA CTD PMID:32145629 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A13 mRNA CTD PMID:30951980 bisphenol A decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SLC6A13 mRNA CTD PMID:25181051 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of SLC6A13 mRNA CTD PMID:30951980 calcium silicate increases expression EXP 6480464 calcium silicate results in increased expression of SLC6A13 mRNA CTD PMID:29279043 cisplatin decreases expression ISO SLC6A13 (Homo sapiens) 6480464 Cisplatin results in decreased expression of SLC6A13 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SLC6A13 mRNA CTD PMID:27392435 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of SLC6A13 mRNA CTD PMID:17585979 clofibric acid affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 Clofibric Acid affects the expression of SLC6A13 mRNA CTD PMID:17602206 coumarin decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 coumarin results in decreased expression of SLC6A13 mRNA CTD PMID:18480146 crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of SLC6A13 mRNA CTD PMID:29279043 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of SLC6A13 mRNA CTD PMID:24205000 diquat increases expression EXP 6480464 Diquat results in increased expression of SLC6A13 mRNA CTD PMID:36851058 endosulfan decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of SLC6A13 mRNA CTD PMID:29391264 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of SLC6A13 mRNA CTD PMID:35436446 ethyl methanesulfonate increases expression ISO SLC6A13 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of SLC6A13 mRNA CTD PMID:23649840 flavonoids decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Flavonoids results in decreased expression of SLC6A13 mRNA CTD PMID:18035473 fluconazole decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Fluconazole results in decreased expression of SLC6A13 mRNA CTD PMID:16643972 flutamide decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Flutamide results in decreased expression of SLC6A13 mRNA CTD PMID:24136188 furan decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 furan results in decreased expression of SLC6A13 mRNA CTD PMID:25539665 gamma-aminobutyric acid increases export ISO SLC6A13 (Homo sapiens) 6480464 SLC6A13 results in increased export of gamma-Aminobutyric Acid CTD PMID:21748804 graphite affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 Graphite affects the expression of SLC6A13 mRNA CTD PMID:29933104 GW 4064 increases expression EXP 6480464 GW 4064 results in increased expression of SLC6A13 mRNA CTD PMID:26655953 hydralazine multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A13 mRNA CTD PMID:17183730 leflunomide increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 leflunomide results in increased expression of SLC6A13 mRNA CTD PMID:24136188 Licochalcone B increases expression ISO SLC6A13 (Homo sapiens) 6480464 licochalcone B results in increased expression of SLC6A13 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SLC6A13 mRNA CTD PMID:35811015 methamphetamine multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC6A13 mRNA CTD PMID:19564919 methamphetamine decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Methamphetamine results in decreased expression of SLC6A13 mRNA CTD PMID:19564919 methidathion decreases expression EXP 6480464 methidathion results in decreased expression of SLC6A13 mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO SLC6A13 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of SLC6A13 mRNA CTD PMID:23649840 Muraglitazar increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 muraglitazar results in increased expression of SLC6A13 mRNA CTD PMID:21515302 N-nitrosodiethylamine decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Diethylnitrosamine results in decreased expression of SLC6A13 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC6A13 mRNA CTD PMID:28943392 N-Nitrosopyrrolidine decreases expression ISO SLC6A13 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of SLC6A13 mRNA CTD PMID:32234424 nitrofen increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 nitrofen results in increased expression of SLC6A13 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO SLC6A13 (Homo sapiens) 6480464 methyleugenol results in decreased expression of SLC6A13 mRNA CTD PMID:32234424 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC6A13 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of SLC6A13 mRNA CTD PMID:37315490 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A13 mRNA CTD PMID:36331819 phenobarbital decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Phenobarbital results in decreased expression of SLC6A13 mRNA CTD PMID:19162173 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC6A13 mRNA CTD PMID:23811191 potassium chromate increases expression ISO SLC6A13 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC6A13 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A13 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in increased expression of SLC6A13 mRNA CTD PMID:19162173 resveratrol multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC6A13 mRNA CTD PMID:23557933 rotenone increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Rotenone results in increased expression of SLC6A13 mRNA CTD PMID:28374803 rotenone decreases expression ISO SLC6A13 (Homo sapiens) 6480464 Rotenone results in decreased expression of SLC6A13 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO SLC6A13 (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of SLC6A13 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SLC6A13 mRNA CTD PMID:35811015 SCH 23390 decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 SCH 23390 results in decreased expression of SLC6A13 mRNA CTD PMID:19564919 SCH 23390 multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SLC6A13 mRNA CTD PMID:19564919 silver atom increases expression ISO SLC6A13 (Homo sapiens) 6480464 Silver results in increased expression of SLC6A13 mRNA CTD PMID:26014281 silver(0) increases expression ISO SLC6A13 (Homo sapiens) 6480464 Silver results in increased expression of SLC6A13 mRNA CTD PMID:26014281 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A13 mRNA CTD PMID:21641980 and PMID:23086747 Tesaglitazar increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 tesaglitazar results in increased expression of SLC6A13 mRNA CTD PMID:21515302 testosterone increases expression ISO SLC6A13 (Homo sapiens) 6480464 Testosterone results in increased expression of SLC6A13 mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of SLC6A13 mRNA and Carbon Tetrachloride results in decreased expression of SLC6A13 protein CTD PMID:17544377 and PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC6A13 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC6A13 mRNA] CTD PMID:31150632 Theaflavin 3,3'-digallate affects expression ISO SLC6A13 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of SLC6A13 mRNA CTD PMID:34925699 thioacetamide multiple interactions ISO Slc6a13 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SLC6A13 mRNA CTD PMID:28943392 thioacetamide decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of SLC6A13 mRNA CTD PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of SLC6A13 mRNA CTD PMID:23557971 toluene affects expression ISO Slc6a13 (Rattus norvegicus) 6480464 Toluene affects the expression of SLC6A13 mRNA CTD PMID:18653662 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of SLC6A13 mRNA CTD PMID:29279043 triadimefon decreases expression ISO Slc6a13 (Rattus norvegicus) 6480464 triadimefon results in decreased expression of SLC6A13 mRNA CTD PMID:16643972 triclosan increases expression ISO SLC6A13 (Homo sapiens) 6480464 Triclosan results in increased expression of SLC6A13 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of SLC6A13 mRNA CTD PMID:19042947 troglitazone increases expression ISO Slc6a13 (Rattus norvegicus) 6480464 troglitazone results in increased expression of SLC6A13 mRNA CTD PMID:21515302 valproic acid multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of SLC6A13 mRNA CTD PMID:17183730 zinc atom multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC6A13 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO SLC6A13 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC6A13 mRNA CTD PMID:18593933